Literature DB >> 26704434

Direct intranigral injection of dopaminochrome causes degeneration of dopamine neurons.

Jillienne C Touchette1, Julie M Breckenridge1, Gerald H Wilken1, Heather Macarthur2.   

Abstract

Parkinson's disease (PD) is characterized by progressive neurodegeneration of nigrastriatal dopaminergic neurons leading to clinical motor dysfunctions. Many animal models of PD have been developed using exogenous neurotoxins and pesticides. Evidence strongly indicates that the dopaminergic neurons of the substantia nigra pars compacta (SNpc) are highly susceptible to neurodegeneration due to a number of factors including oxidative stress and mitochondrial dysfunction. Oxidation of DA to a potential endogenous neurotoxin, dopaminochrome (DAC), may be a potential contributor to the vulnerability of the nigrostriatal tract to oxidative insult. In this study, we show that DAC causes slow and progressive degeneration of dopaminergic neurons in contrast to 1-methyl-4-phenylpyridinium (MPP(+)), which induces rapid lesions of the region. The DAC model may be more reflective of early stresses that initiate the progressive neurodegenerative process of PD, and may prove a useful model for future neurodegenerative studies.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Dopamine; Neurodegeneration; Oxidation; Parkinson’s disease; Substantia nigra pars compacta

Mesh:

Substances:

Year:  2015        PMID: 26704434      PMCID: PMC4728017          DOI: 10.1016/j.neulet.2015.12.028

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  63 in total

Review 1.  The functional anatomy of disorders of the basal ganglia.

Authors:  R L Albin; A B Young; J B Penney
Journal:  Trends Neurosci       Date:  1995-02       Impact factor: 13.837

2.  Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra.

Authors:  G Costa; J A Abin-Carriquiry; F Dajas
Journal:  Brain Res       Date:  2001-01-12       Impact factor: 3.252

3.  The parkinsonian toxin MPTP: action and mechanism.

Authors:  Serge Przedborski; Vernice Jackson-Lewis; Ruth Djaldetti; Gabriel Liberatore; Miquel Vila; Slobodanka Vukosavic; Gabrielle Almer
Journal:  Restor Neurol Neurosci       Date:  2000       Impact factor: 2.406

4.  Catecholamines oxidation by xanthine oxidase.

Authors:  C Foppoli; R Coccia; C Cini; M A Rosei
Journal:  Biochim Biophys Acta       Date:  1997-03-15

5.  Tyrosinase exacerbates dopamine toxicity but is not genetically associated with Parkinson's disease.

Authors:  Elisa Greggio; Elisabetta Bergantino; Donald Carter; Rili Ahmad; Gertrude-Emilia Costin; Vincent J Hearing; Jordi Clarimon; Andrew Singleton; Johanna Eerola; Olli Hellström; Pentti J Tienari; David W Miller; Alexandra Beilina; Luigi Bubacco; Mark R Cookson
Journal:  J Neurochem       Date:  2005-04       Impact factor: 5.372

6.  Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.

Authors:  K A Conway; J C Rochet; R M Bieganski; P T Lansbury
Journal:  Science       Date:  2001-11-09       Impact factor: 47.728

7.  Cytotoxicity of dopaminochrome in the mesencephalic cell line, MN9D, is dependent upon oxidative stress.

Authors:  Andrew J Linsenbardt; Gerald H Wilken; Thomas C Westfall; Heather Macarthur
Journal:  Neurotoxicology       Date:  2009-07-18       Impact factor: 4.294

8.  MPP(+)-induced degeneration is potentiated by dicoumarol in cultures of the RCSN-3 dopaminergic cell line. Implications of neuromelanin in oxidative metabolism of dopamine neurotoxicity.

Authors:  R Aguilar Hernández; M J Sánchez De Las Matas; C Arriagada; C Barcia; P Caviedes; M T Herrero; J Segura-Aguilar
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

9.  A 6-hydroxydopamine-induced selective parkinsonian rat model.

Authors:  D A Perese; J Ulman; J Viola; S E Ewing; K S Bankiewicz
Journal:  Brain Res       Date:  1989-08-14       Impact factor: 3.252

Review 10.  The neuromelanin of human substantia nigra: structure, synthesis and molecular behaviour.

Authors:  L Zecca; F A Zucca; P Costi; D Tampellini; A Gatti; M Gerlach; P Riederer; R G Fariello; S Ito; M Gallorini; D Sulzer
Journal:  J Neural Transm Suppl       Date:  2003
View more
  6 in total

Review 1.  The usual suspects, dopamine and alpha-synuclein, conspire to cause neurodegeneration.

Authors:  Danielle E Mor; Malcolm J Daniels; Harry Ischiropoulos
Journal:  Mov Disord       Date:  2019-01-11       Impact factor: 10.338

2.  The Neurotoxin DSP-4 Induces Hyperalgesia in Rats that is Accompanied by Spinal Oxidative Stress and Cytokine Production.

Authors:  Jillienne C Touchette; Joshua W Little; Gerald H Wilken; Daniela Salvemini; Heather Macarthur
Journal:  Neuroscience       Date:  2018-02-05       Impact factor: 3.590

3.  Overexpression of Vesicular Monoamine Transporter-2 may Block Neurotoxic Metabolites from Cytosolic Dopamine: a Potential Neuroprotective Therapy for Parkinson's Disease.

Authors:  David Sulzer; Fabio A Zucca; Luigi Zecca
Journal:  Clin Pharmacol Transl Med       Date:  2019-05-06

4.  Aminochrome induces dopaminergic neuronal dysfunction: a new animal model for Parkinson's disease.

Authors:  Andrea Herrera; Patricia Muñoz; Irmgard Paris; Gabriela Díaz-Veliz; Sergio Mora; Jose Inzunza; Kjell Hultenby; Cesar Cardenas; Fabián Jaña; Rita Raisman-Vozari; Katia Gysling; Jorge Abarca; Harry W M Steinbusch; Juan Segura-Aguilar
Journal:  Cell Mol Life Sci       Date:  2016-03-21       Impact factor: 9.261

5.  The Effect of Oxidized Dopamine on the Structure and Molecular Chaperone Function of the Small Heat-Shock Proteins, αB-Crystallin and Hsp27.

Authors:  Junna Hayashi; Jennifer Ton; Sparsh Negi; Daniel E K M Stephens; Dean L Pountney; Thomas Preiss; John A Carver
Journal:  Int J Mol Sci       Date:  2021-04-02       Impact factor: 5.923

6.  Cationic Carbosilane Dendrimers Prevent Abnormal α-Synuclein Accumulation in Parkinson's Disease Patient-Specific Dopamine Neurons.

Authors:  Raquel Ferrer-Lorente; Tania Lozano-Cruz; Irene Fernández-Carasa; Katarzyna Miłowska; Francisco Javier de la Mata; Maria Bryszewska; Antonella Consiglio; Paula Ortega; Rafael Gómez; Angel Raya
Journal:  Biomacromolecules       Date:  2021-10-06       Impact factor: 6.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.